Mongrel or beagle dogs were submitted to bile duct ligation, or to extraenteric biliary diversion by means of choledochoureterostomy. The kinetics of intravenously administered FK506 was not changed from control status two weeks after bile duct ligation, but the bioavailability of orally administered FK506 was nearly quadrupled. Following oral administration, the absorption of FK506 was highly variable. The results indicate that in dogs FK506 is absorbed from the intestine just as efficiently in the absence of enteric bile and in presence of exogenous bile salt supplement when compared with its absorption in presence of normal bile drainage. These findings with FK506 are different from those with cyclosporine after biliary obstruction or di...
FK 506 was tested in unrelated baboons submitted to renal transplantation and bilateral native nephr...
Numerous clinical reports have documented an increase in trough blood concentrations of cyclosporine...
FK 506 was given for immunosuppression in 14 liver recipients. The drug was used in the first 10 cas...
FK506 is the most potent immunosuppressive agent known. Its toxicity is substantial in dogs, minor i...
Ten dogs that survived the perioperative events of liver transplantation were treated with 1 mg/kg/d...
In dogs the most effective oral dose of FK 506 for prevention of renal homograft rejection was 1.5 m...
Portacaval shunt (Eck fistula) in dogs causes hepato- cyte atrophy and organelle disruption, as well...
The immunosuppressive agent FK permitted increased kidney transplant survival in dogs over a wide do...
A technique of bile diversion by tube choledochoureterostomy has been devised for the purpose of stu...
FK 506 is a superior immunosuppressive agent that should improve the grafting of organs that already...
Malononitrilamide 715 (FK778) is a new class of immunosuppressant, derived from the active metabolit...
A procedure for cannulating the bile duct of the dog is described. An intramuscular injection of Gen...
Malononitrilamide 715 (FK778) is a new class of immunosuppressant, derived from the active metabolit...
BACKGROUND: To physiologically reconstruct the biliary tract, Crema et al suggested the application ...
Small intestine allotransplantation in humans is not yet feasible due to the failure of the current ...
FK 506 was tested in unrelated baboons submitted to renal transplantation and bilateral native nephr...
Numerous clinical reports have documented an increase in trough blood concentrations of cyclosporine...
FK 506 was given for immunosuppression in 14 liver recipients. The drug was used in the first 10 cas...
FK506 is the most potent immunosuppressive agent known. Its toxicity is substantial in dogs, minor i...
Ten dogs that survived the perioperative events of liver transplantation were treated with 1 mg/kg/d...
In dogs the most effective oral dose of FK 506 for prevention of renal homograft rejection was 1.5 m...
Portacaval shunt (Eck fistula) in dogs causes hepato- cyte atrophy and organelle disruption, as well...
The immunosuppressive agent FK permitted increased kidney transplant survival in dogs over a wide do...
A technique of bile diversion by tube choledochoureterostomy has been devised for the purpose of stu...
FK 506 is a superior immunosuppressive agent that should improve the grafting of organs that already...
Malononitrilamide 715 (FK778) is a new class of immunosuppressant, derived from the active metabolit...
A procedure for cannulating the bile duct of the dog is described. An intramuscular injection of Gen...
Malononitrilamide 715 (FK778) is a new class of immunosuppressant, derived from the active metabolit...
BACKGROUND: To physiologically reconstruct the biliary tract, Crema et al suggested the application ...
Small intestine allotransplantation in humans is not yet feasible due to the failure of the current ...
FK 506 was tested in unrelated baboons submitted to renal transplantation and bilateral native nephr...
Numerous clinical reports have documented an increase in trough blood concentrations of cyclosporine...
FK 506 was given for immunosuppression in 14 liver recipients. The drug was used in the first 10 cas...